Biotechnology Stocks I Performance Guide: Neumora Therapeutics, Inc. (NMRA)
NMRA has no dividends
Table and Chart of NMRA Performance
See what a $1,000 investment in NMRA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NMRA Returns | |
|---|---|
| Start Date | Oct-31-2023 |
| Start Price | $10.92 |
| End Date | Dec-01-2023 |
| End Price | $12.33 |
| # Prices | 3 |
| Min Date | Oct-31-2023 |
| Min Price | $10.92 |
| Max Date | Dec-01-2023 |
| Max Price | $12.33 |
| Total Return | 12.91% |
| Annualized Return | 62.54% |
| Current Value of $1,000 Purchase | $1,129 |
| Number Returns | 3 |
| Average Return | 8.58% |
| Number Profitable Returns | 3 |
| Percent Profitable Returns | 100.00% |
| Number Unprofitable Returns | 0 |
| Percent Unprofitable Returns | 0.00% |
| Profitable to Unprofitable Returns Ratio | 1.00 |
| NMRA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,862,895,000 | Price to Sales |
| Earnings per Share | $-0.8700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $17.74 |
| 52 Week Low | $9.35 |
| Analyst Target Price | $None |
| 50-Day Moving Average | $11.67 |
| 200-Day Moving Average | $11.67 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.396% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NMRA Compare Returns with S&P 500
NMRA Trendline Chart